Erlotinib impurity 134
- CASnot assigned
- CatalogueRS-E003160
- FormulaC14H18N2O10
- MW374.3
CUSTOM SYNTHESIS
On this page
Product identification
| Product name | Erlotinib impurity 134 |
|---|---|
| Catalogue No. | RS-E003160 |
| CAS No. | not assigned |
| Molecular formula | C14H18N2O10 |
| Molecular weight | 374.3 |
| Exact mass | 374.0961 (monoisotopic) |
| InChIKey | WTKXIJCJNGQKMM-UHFFFAOYSA-N |
| Availability | Custom synthesis— made to order, typically 3–4 weeks |
| Standard type | Impurity Reference Standards |
| Drug substance | Erlotinib |
| Storage | Refer to the certificate of analysis (COA) supplied with each lot |
| Pack sizes | 25mg |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-E003160 / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
A certificate of analysis (COA) is issued for the lot you receive. It records the catalogue number
RS-E003160 and the batch number, the tests performed, the
specification applied and the result obtained. A safety data sheet is supplied with the shipment.
Is the assigned value given on an “as is” basis?
Content and purity are stated per lot on the certificate of analysis, on an “as is” basis unless the certificate says otherwise. The analytical basis for the assigned value is stated on the certificate.
How should this material be stored?
Store as stated: Refer to the certificate of analysis (COA) supplied with each lot. Re-test before use beyond the retest date printed on the certificate.
Do you supply pack sizes other than those listed?
Pack sizes are confirmed with the quotation. Quantities beyond the standard pack sizes can be quoted — send the quantity you need with your enquiry.
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Erlotinib
- Impurity Reference Standards of this kind
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-E003160
- Request a quotation for RS-E003160
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Erlotinib
All 121 further standards are on this page — 20 shown at first, then 20 more per click on Load more.
Erlotinib
IN STOCKRS-U095174Erlotinib Acetate
IN STOCKRS-E003021Erlotinib Mesylate
BACK ORDERRS-U095667Erlotinib EP Impurity D
IN STOCKRS-E003046Erlotinib EP Impurity F
BACK ORDERRS-E003037Erlotinib EP Impurity I
IN STOCKRS-E003019Erlotinib Impurity C
IN STOCKRS-E003050Erlotinib impurity G
BACK ORDERRS-Z401GBL(Z)-1-(2-Bromovinyl)-3-nitrobenzene (Erlotinib Impurity)
BACK ORDERRS-I0490302-((4-Amino-7-(2-methoxyethoxy)quinazolin-6-yl)oxy)ethan-1-ol
IN STOCKRS-E0030202-Chloroethyl Methyl Ether
IN STOCKRS-U0718632-Methoxyethyl 3,4-bis(2-methoxyethoxy)benzoate (Erlotinib Impurity)
IN STOCKRS-M8300222-Methyl-3-butyn-2-ol
IN STOCKRS-U0530352-Methyl-4-(3-nitrophenyl)but-3-yn-2-ol
CUSTOM SYNTHESISRS-P0119593-((6,7-Bis(2-methoxyethoxy)quinazolin-4-yl)amino)benzoic acid hydrochloride
BACK ORDERRS-U0555133-(3-Nitrophenyl)-3-oxopropanal
IN STOCKRS-Z004BRZ3-Bromonitrobenzene
IN STOCKRS-P0037763-Ethynylaniline
IN STOCKRS-C0580303-Ethynylaniline hydrochloride
CUSTOM SYNTHESISRS-U0081273-Nitrocinnamic Acid
IN STOCKRS-N1879010Erlotinib EP Impurity E
IN STOCKRS-E0250013-Vinylaniline Hydrochloride
IN STOCKRS-U0073216,6',7,7'-tetrakis(2-methoxyethoxy)-4H-[3,4'-biquinazolin]-4-one
CUSTOM SYNTHESISRS-E0031196,7-bis(2-hydroxyethoxy)quinazolin-4(3H)-one
IN STOCKRS-E0031306,7-Bis(2-methoxyethoxy)-4-isopropoxyquinazoline
IN STOCKRS-I0121716,7-bis(2-methoxyethoxy)quinazolin-4-ol
CUSTOM SYNTHESISRS-E0031066,7-Diacetoxy-4-chloroquinazoline
IN STOCKRS-Z412AFC6-hydroxy-7-(2-methoxyethoxy)quinazolin-4(3H)-one
IN STOCKRS-E0031267-(2-hydroxyethoxy)-6-(2-methoxyethoxy)quinazolin-4(3H)-one
IN STOCKRS-E0031297-O-Desmethoxy-7-O-chloroethyl Erlotinib
IN STOCKRS-E003043Desethynyl Erlotinib
IN STOCKRS-E003032Desmethyl Erlotinib Acetate
CUSTOM SYNTHESISRS-E003041Erlotinib 13C6 Hydrochloride
BACK ORDERRS-E003066Erlotinib aldehyde
IN STOCKRS-E003034Erlotinib D4
IN STOCKRS-E003031Erlotinib D6
BACK ORDERRS-E003067Erlotinib Hydrochloride (Polymorph B)
IN STOCKRS-I006034Erlotinib Impurity, 6,7-bis(2-chloroethoxy)
BACK ORDERRS-I006035Erlotinib Impurity, 6-(2-chloroethoxy)-7-(2-methoxyethoxy)
IN STOCKRS-E003042Erlotinib Metabolite M11
IN STOCKRS-D115046Erlotinib O-Desmethyl Metabolite (M14)
IN STOCKRS-E003044Erlotinib O-Desmethyl Metabolite Isomer (M13) HCl
IN STOCKRS-D003141Erlotinib O-Desmethyl Metabolite Isomer (M14) HCl
IN STOCKRS-D003140Erlotinib-d6 HCl
IN STOCKRS-Z400M09Ethyl 3,4-bis(2-methoxyethoxy)-2-nitrobenzoate
CUSTOM SYNTHESISRS-D115077Ethyl 3,4-dihydroxybenzoate
IN STOCKRS-E003024Ethyl 3-hydroxy-4-(2-methoxyethoxy)benzoate
IN STOCKRS-D115001Gefitinib Impurity (6,7-Dimethoxy-3,4-dihydroquinazoline-4-one)
IN STOCKRS-I047013N-(2-Methoxyethyl) Erlotinib
IN STOCKRS-E003064N-(3-Ethynylphenyl)-7,8-bis(2-methoxyethoxy)quinazolin-4-amine
BACK ORDERRS-U057793N-(4-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine
CUSTOM SYNTHESISRS-D114003N-[4-(Acetyloxy)-3-methoxyphenyl]-acetamide
BACK ORDERRS-U057157OSI-420-d4
IN STOCKRS-I104029Phenylsulfamoyl Chloride
IN STOCKRS-Z401JOMPropyl 2-amino-4,5-bis(2-methoxyethoxy)benzoate
IN STOCKRS-D126037Protocatechuic acid(3,4-Dihydroxybenzoic acid)
IN STOCKRS-U084268Tetrahydro Erlotinib
IN STOCKRS-E003022Erlotinib Impurity 6
BACK ORDERRS-E003040Erlotinib Impurity 7
BACK ORDERRS-E003014Erlotinib Impurity 8
BACK ORDERRS-E003007Erlotinib Impurity 9 Hydrochloride
IN STOCKRS-E003049Erlotinib Impurity 10
IN STOCKRS-E003045Erlotinib Impurity 13
IN STOCKRS-E066001Erlotinib Impurity 17
CUSTOM SYNTHESISRS-E003052Erlotinib Impurity 18
IN STOCKRS-E003057Erlotinib Impurity 19
IN STOCKRS-E003006Erlotinib Impurity 21
IN STOCKRS-E003053Erlotinib Impurity 22
IN STOCKRS-E003054Erlotinib Impurity 31
CUSTOM SYNTHESISRS-E003058Erlotinib Impurity 32
IN STOCKRS-E003056Erlotinib Impurity 36 HCl
CUSTOM SYNTHESISRS-E003008Erlotinib Impurity 39
IN STOCKRS-E003018Erlotinib Impurity 39
IN STOCKRS-I001771Erlotinib Impurity 41
CUSTOM SYNTHESISRS-Z412M1VErlotinib Impurity 44 (1470063-80-9)
IN STOCKRS-E003068Erlotinib Impurity 46 (476168-17-9)
IN STOCKRS-E003069Erlotinib Impurity 47
IN STOCKRS-Z412PIGErlotinib Impurity 54
CUSTOM SYNTHESISRS-E003002Erlotinib Impurity 61
CUSTOM SYNTHESISRS-E003048Erlotinib Impurity 62
CUSTOM SYNTHESISRS-E003036Erlotinib Impurity 75
IN STOCKRS-E003013Erlotinib Impurity 80
CUSTOM SYNTHESISRS-Z401GC5Erlotinib Impurity 96
IN STOCKRS-I001AIOErlotinib Impurity 100
IN STOCKRS-E003029Erlotinib Impurity 104
IN STOCKRS-I001AGDErlotinib Impurity 107
BACK ORDERRS-Z401HH3Erlotinib Impurity 108
IN STOCKRS-I001B1OErlotinib impurity 131
IN STOCKRS-E003161Erlotinib impurity 132
IN STOCKRS-E003158Erlotinib impurity 133
IN STOCKRS-I001A10Erlotinib Impurity 135
IN STOCKRS-E003010Erlotinib Impurity 136
IN STOCKRS-E003030Erlotinib Impurity 137
IN STOCKRS-E003062Erlotinib Impurity 167
IN STOCKRS-E003001Erlotinib Impurity 168
IN STOCKRS-E003003Erlotinib Impurity 169
IN STOCKRS-E003004Erlotinib Impurity 170
CUSTOM SYNTHESISRS-E003005Erlotinib Impurity 171
IN STOCKRS-E003009Erlotinib Impurity 172
IN STOCKRS-E003011Erlotinib Impurity 173
IN STOCKRS-E003012Erlotinib Impurity 174
IN STOCKRS-E003015Erlotinib Impurity 175
IN STOCKRS-E003016Erlotinib Impurity 176
IN STOCKRS-E003017Erlotinib Impurity 177
IN STOCKRS-E003023Erlotinib Impurity 178
IN STOCKRS-E003025Erlotinib Impurity 179
IN STOCKRS-E003026Erlotinib Impurity 180
IN STOCKRS-E003027Erlotinib Impurity 181
IN STOCKRS-E003028Erlotinib Impurity 182
IN STOCKRS-E003033Erlotinib Impurity 183
CUSTOM SYNTHESISRS-E003035Erlotinib Impurity 184
IN STOCKRS-E003038Erlotinib Impurity 185
BACK ORDERRS-E003039Erlotinib Impurity 186
IN STOCKRS-E003047Erlotinib Impurity 187
IN STOCKRS-E003051Erlotinib Impurity 189
IN STOCKRS-E003059Erlotinib Impurity 190
IN STOCKRS-E003060Erlotinib Impurity 191
IN STOCKRS-E003061Erlotinib Impurity 192
CUSTOM SYNTHESISRS-E003063Erlotinib Impurity 193
IN STOCKRS-E003065
![Chemical structure of N-[4-(Acetyloxy)-3-methoxyphenyl]-acetamide](/structures/w4/WQDQWNJLJOPHHC-UHFFFAOYSA-N.webp?v=11)
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.